2-Substituted oxazolyl and thiazolyl amino acids are suitable P1 surrogates for new SARS-CoV-2 main protease inhibitors
Organic & Biomolecular Chemistry · 2026 · 24 (23) · 4943-4951
DOI: 10.1039/d6ob00697c ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic & Biomolecular Chemistry, 2026. Verfasst von Zijie Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Alberta, Edmonton, AB, T6G 2G2, Canada. john.vederas@ualberta.ca. Hauptthemen laut MEDLINE: Coronavirus 3C Proteases, Amino Acids, SARS-CoV-2, Thiazoles. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Synthesis of enantiopure heteroazole amino acid building blocks from commercially available materials for incorporation into SARS-CoV-2 M pro inhibitors as alternatives to the cyclic glutamine P1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Alberta, Edmonton, AB, T6G 2G2, Canada. john.vederas@ualberta.ca.
ORCID-Profile: Tayla J Van Oers, Conrad Fischer, John C Vederas
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Liu, Z., Van Oers, T. J., Fischer, C., Nguyen, A., Chew, J., & Vederas, J. C. (2026). 2-Substituted oxazolyl and thiazolyl amino acids are suitable P1 surrogates for new SARS-CoV-2 main protease inhibitors. Organic & Biomolecular Chemistry, 24(23), 4943-4951. https://doi.org/10.1039/d6ob00697c
Vancouver
Liu Z, Van Oers TJ, Fischer C, Nguyen A, Chew J, Vederas JC. 2-Substituted oxazolyl and thiazolyl amino acids are suitable P1 surrogates for new SARS-CoV-2 main protease inhibitors. Organic & Biomolecular Chemistry. 2026;24(23):4943-4951. doi:10.1039/d6ob00697c
BibTeX
@article{Liu2026,
author = {Liu, Zijie and Van Oers, Tayla J and Fischer, Conrad and Nguyen, Anna and Chew, Johnson and Vederas, John C},
title = {2-Substituted oxazolyl and thiazolyl amino acids are suitable P1 surrogates for new SARS-CoV-2 main protease inhibitors},
journal = {Organic & Biomolecular Chemistry},
year = {2026},
volume = {24},
number = {23},
pages = {4943--4951},
doi = {10.1039/d6ob00697c}
}
EUVIMED